Jennifer J Knox

Jennifer J Knox, MSc, MD, FRCPC

Research interests include clinical and translational research in new drug development, gastrointestinal and genito-urinary malignancies. Dr. Knox is also the Principal Investigator of trials in biliary, hepatocellular, esophageal and renal cell cancers.
Clin Cancer Res. 2017 Dec 29;:
Aung KL, Fischer SE, Denroche RE, Jang GH, Dodd A, Creighton S, Southwood B, Liang SB, Chadwick D, Zhang A, O'Kane GM, Albaba HAA, Moura S, Grant RC, Miller JK, Mbabaali F, Pasternack D, Lungu IM, Bartlett JMS, Ghai S, Lemire M, Holter S, Connor AA,...
Curr Probl Cancer. 2017 Nov 16;:
O Kane GM, Knox JJ
Curr Probl Cancer. 2017 Nov 14;:
Sim HW, Knox J
Clin Colorectal Cancer. 2017 Oct 23;:
Chiu JW, Krzyzanowska MK, Serra S, Knox JJ, Dhani NC, Mackay H, Hedley D, Moore M, Liu G, Burkes RL, Brezden-Masley C, Roehrl MH, Craddock KJ, Tsao MS, Zhang T, Yu C, Kamel-Reid S, Siu LL, Bedard PL, Chen EX
Surg Oncol Clin N Am. 2017 Oct;26(4):647-666
Sim HW, Knox J, Dawson LA
Mol Carcinog. 2017 Sep 11;:
Pasic I, Wong KM, John Lee J, Espin-Garcia O, Brhane Y, Cheng D, Chen Z, Patel D, Brown C, Bucur R, Reisman D, Knox JJ, Xu W, Hung RJ, Guo G, Cleary SP
Cell Immunol. 2017 Jul 11;:
Knox JJ, Kaplan DE, Betts MR
J Gastrointest Oncol. 2017 Apr;8(2):352-360
Doherty MK, McNamara MG, Aneja P, McInerney E, Moignard S, Horgan AM, Jiang H, Panzarella T, Jang R, Dhani N, Hedley D, Knox JJ
Oncotarget. 2017 03 03;:
Korpanty GJ, Eng L, Qiu X, Faluyi OO, Renouf DJ, Cheng D, Patel D, Chen Z, Tse BC, Knox JJ, Dodbiba L, Teichman J, Azad AK, Wong R, Darling G, Reisman D, Cuffe S, Liu G, Xu W
Dis Esophagus. 2016 Nov;29(8):1152-1158
Horgan AM, Darling G, Wong R, Guindi M, Liu G, Jonker DJ, Lister J, Xu W, MacKay HM, Dinniwell R, Kim J, Pierre A, Shargall Y, Asmis TR, Agboola O, Seely AJ, Ringash J, Wells J, Marginean EC, Haider M, Knox JJ

Pages


 

Associate Professor, Department of Medicine, University of Toronto
Chair, Kidney Disease Oriented Group, National Cancer Institute of Canada
Chair, Hepatobiliary Disease Oriented Group, National Cancer Institute of Canada